By Josh White
Date: Thursday 30 Jul 2026
(Sharecast News) - Elementis reported first-half revenue of $318.2m on Thursday, up 9.4% on a reported basis and 4.7% organically at constant currencies, while adjusted operating profit rose 16.4% to $73.2m.
By Michele Maatouk
Date: Tuesday 02 Jun 2026
(Sharecast News) - Elementis shot higher on Tuesday after saying it will return around $35m of net cash proceeds to shareholders following completion of the sale of its pharmaceutical manufacturing business.
By Michele Maatouk
Date: Wednesday 29 Apr 2026
(Sharecast News) - Elementis backed its full-year expectations on Wednesday and reported a rise in first-quarter profit and revenue as its 'Elevate Elementis' strategy delivers ahead of plan.
| Currency | UK Pounds |
| Share Price | 178.80p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 187.20p |
| 52 Week Low | 142.60p |
| Volume | 0 |
| Shares Issued | 565.13m |
| Market Cap | £1,010.46m |
| RiskGrade | 191 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 1 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 13-Aug-26 | 30-Apr-26 |
| Paid | 25-Sep-26 | 29-May-26 |
| Amount | 1.50¢ | 3.00¢ |
| CEO | Luc van Ravenstein |
| CFO | Kath Kearney-Croft |
You are here: research